Zacks Bull and Bear of the Day Highlights: AtheroGenics, ProQuest Company, Bayer A.G. and Yahoo!CHICAGO -- Zacks Equity Research highlights AtheroGenics, Inc. (Nasdaq:AGIX AGIX AtheroGenics, Inc (stock symbol) ) as the Bull of the Day and ProQuest Company (NYSE NYSE
See: New York Stock Exchange :PQE PQE Post Qualification Experience
PQE Print Quality Enhancement
PQE Province of Quebec
PQE Preliminary Qualifying Exam
PQE Project Quality Engineering
PQE Procurement Quality Engineering
PQE point quotation explanation
PQE Pragmatic Quality Evaluation ) as the Bear of the Day. In addition, Zacks Equity Research provides analysis on Bayer A.G. (NYSE:BAY) and Yahoo! (Nasdaq:YHOO YHOO Yahoo! Inc. (NASDAQ symbol) ). Full analysis of all four stocks is available at http://at.zacks.com/?id=2676.
Here is a synopsis of all four stocks:
Bull of the Day:
Our Bull of the Day recommendation is for AtheroGenics, Inc. (Nasdaq:AGIX), a biotechnology company focused on the discovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases, including heart disease (atherosclerosis), rheumatoid arthritis rheumatoid arthritis
Chronic, progressive autoimmune disease causing connective-tissue inflammation, mostly in synovial joints. It can occur at any age, is more common in women, and has an unpredictable course. and asthma. The company uses its proprietary vascular protectant protectant /pro·tec·tant/ (pro-tek´tant) protective.
1. affording defense or immunity.
2. an agent affording defense against harmful influence. (V-Protectant) technology platform to develop drug candidates. The leading pipeline candidate is AGI-1067 for atherosclerosis. We believe this candidate has billion-dollar blockbuster potential. The shares are attractive given the potential upside ahead. We recommend long-term investors buy the shares.
Bear of the Day:
Our Bear of the Day recommendation is for ProQuest Company (NYSE:PQE). ProQuest expects its accounting review will result in the restatement of earnings reported for fiscal years 2000 to 2004 and for the first three quarters of 2005. The company also provided 2006 revenue and EBIT EBIT
See: Earnings Before Interest and Taxes
See earnings before interest and taxes (EBIT). guidance. Consequently, we have downgraded the stock from a Hold to a Sell, and the target price has been set to $10.
Driven by sales gains and enhanced operating leverage Operating Leverage
A measurement of the degree to which a firm or project relies on fixed rather than variable costs.
The higher the degree of operating leverage, the greater the potential danger from forecasting risk. , Bayer (NYSE:BAY) continues to post impressive results across all its operating segments. The company is investing significantly on research and development in the pharmaceutical and chemical business. Further, the acquisition of Schering AG will strengthen the company's position in the HealthCare business. Moreover, an upturn in the petrochemical cycle and improved chemical pricing power Pricing Power
An economic term referring to the effect that a change in a firm's product price has on the quantity demanded of that product. Pricing power ties in with the "Price Elasticity of Demand. are expected to propel growth further, making the stock fairly attractive to investors. Accordingly, we reiterate our Buy rating, with a target price of $54.50.
We believe as a leader in branded advertising, Yahoo! (Nasdaq:YHOO) will be a prime beneficiary of the shift in advertising spending from traditional media to online media. Yahoo has established itself as a leader in Internet video Video material obtained from the Internet. It may refer to streaming video from real time broadcasts, streaming archival material or downloading video files for watching later, all of which are viewed on the computer. and has grown traffic through upgrades to its existing pages and the launch of new ones. Although investors have been disappointed with recent results, we believe growing traffic will impact the bottom line over the next year. We therefore reiterate our Buy rating on Yahoo with a six-month target price of $40.00.
Get the full analysis of all four stocks by going to http://at.zacks.com/?id=2649.
About the Bull and Bear of the Day
Every day, the analysts at Zacks Equity Research select two stocks that are likely to outperform (Bull) or underperform (Bear) the markets over the next 3-6 months.
About the Analyst Blog
Updated throughout every trading day In Business, the trading day is the time span that a particular stock exchange is open. For example, the New York Stock Exchange is, as of 2006, open from 09:30AM to 4:00PM. Trading days never take place on weekends. , the Analyst Blog provides analysis from Zacks Equity Research about the latest news and events impacting stocks and the financial markets.
About Zacks Equity Research
Zacks Equity Research provides the best of quantitative and qualitative analysis Qualitative Analysis
Securities analysis that uses subjective judgment based on nonquantifiable information, such as management expertise, industry cycles, strength of research and development, and labor relations. to help investors know what stocks to buy and which to sell for the long-term.
Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.
Zacks "Profit from the Pros" e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to Verb 1. subscribe to - receive or obtain regularly; "We take the Times every day"
buy, purchase - obtain by purchase; acquire by means of a financial transaction; "The family purchased a new car"; "The conglomerate acquired a new company"; this free newsletter today by visiting http://at.zacks.com/?id=2677.
Zacks.com is a property of Zacks Investment Research Zacks Investment Research
A firm that compiles earnings estimates and brokerage firm investment recommendations for thousands of publicly traded firms. , Inc., which was formed in 1978 by Leonard Zacks. As a PhD in mathematics Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the Zacks Rank, which continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros by going to http://at.zacks.com/?id=2650.
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
(a)The Zacks Performance Rank performance is the total return of equal weighted simulated portfolios consisting of those stocks with the indicated Zacks Rank net of fees. Results reflect the reinvestment of dividends and other earnings. Simulated results do not represent actual trading and may not reflect the impact that economic and market factors might have had on decision-making if an adviser were actually managing a client's money.
(b)The S&P 500 Index ("S&P 500") is a well-known, unmanaged index of the prices of 500 large-company common stocks selected by Standard & Poor's. The S&P 500 includes the reinvestment of all dividends, no transaction costs Transaction Costs
Costs incurred when buying or selling securities. These include brokers' commissions and spreads (the difference between the price the dealer paid for a security and the price they can sell it). , and represents the gross returns before management fees.
Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.